B-Cell	0	10	Fibroblast	Fibroblast	NN	B-NP
I-Cell	11	17	growth	growth	NN	I-NP
I-Cell	18	24	factor	factor	NN	I-NP
I-Cell	25	33	receptor	receptor	NN	I-NP
I-Cell	34	35	2	2	CD	I-NP
I-Cell	35	36	-	-	HYPH	I-NP
I-Cell	36	44	positive	positive	JJ	I-NP
I-Cell	45	56	fibroblasts	fibroblast	NNS	I-NP
O	57	64	provide	provide	VBP	B-VP
O	65	66	a	a	DT	B-NP
O	67	75	suitable	suitable	JJ	I-NP
O	76	92	microenvironment	microenvironment	NN	I-NP
O	93	96	for	for	IN	B-PP
B-Cancer	97	102	tumor	tumor	NN	B-NP
O	103	114	development	development	NN	I-NP
O	115	118	and	and	CC	O
O	119	130	progression	progression	NN	B-NP
O	131	133	in	in	IN	B-PP
B-Cancer	134	144	esophageal	esophageal	JJ	B-NP
I-Cancer	145	154	carcinoma	carcinoma	NN	I-NP
O	154	155	.	.	.	O

O	156	163	PURPOSE	PURPOSE	NN	B-NP
O	163	164	:	:	:	O
B-Cell	165	170	Tumor	Tumor	NN	B-NP
I-Cell	171	182	fibroblasts	fibroblast	NNS	I-NP
O	183	184	(	(	(	O
B-Cell	184	186	TF	TF	NN	B-NP
O	186	187	)	)	)	O
O	188	192	have	have	VBP	B-VP
O	193	197	been	be	VBN	I-VP
O	198	207	suggested	suggest	VBN	I-VP
O	208	210	to	to	TO	B-VP
O	211	215	play	play	VB	I-VP
O	216	218	an	an	DT	B-NP
O	219	228	essential	essential	JJ	I-NP
O	229	233	role	role	NN	I-NP
O	234	236	in	in	IN	B-PP
O	237	240	the	the	DT	B-NP
O	241	248	complex	complex	JJ	I-NP
O	249	256	process	process	NN	I-NP
O	257	259	of	of	IN	B-PP
B-Cancer	260	265	tumor	tumor	NN	B-NP
O	265	266	-	-	HYPH	B-NP
B-Tissue	266	272	stroma	stroma	NN	I-NP
O	273	285	interactions	interaction	NNS	I-NP
O	286	289	and	and	CC	I-NP
O	290	303	tumorigenesis	tumorigenesis	NN	I-NP
O	303	304	.	.	.	O

O	305	308	The	The	DT	B-NP
O	309	312	aim	aim	NN	I-NP
O	313	315	of	of	IN	B-PP
O	316	319	the	the	DT	B-NP
O	320	327	present	present	JJ	I-NP
O	328	333	study	study	NN	I-NP
O	334	337	was	be	VBD	B-VP
O	338	340	to	to	TO	B-VP
O	341	352	investigate	investigate	VB	I-VP
O	353	356	the	the	DT	B-NP
O	357	365	specific	specific	JJ	I-NP
O	366	370	role	role	NN	I-NP
O	371	373	of	of	IN	B-PP
B-Cell	374	376	TF	TF	NN	B-NP
O	377	379	in	in	IN	B-PP
O	380	383	the	the	DT	B-NP
B-Cancer	384	394	esophageal	esophageal	JJ	I-NP
I-Cancer	395	401	cancer	cancer	NN	I-NP
O	402	418	microenvironment	microenvironment	NN	I-NP
O	418	419	.	.	.	O

O	420	432	EXPERIMENTAL	EXPERIMENTAL	JJ	B-NP
O	433	439	DESIGN	DESIGN	NN	I-NP
O	439	440	:	:	:	O
O	441	443	An	An	DT	B-NP
O	444	454	Affymetrix	Affymetrix	NN	I-NP
O	455	465	expression	expression	NN	I-NP
O	466	476	microarray	microarray	NN	I-NP
O	477	480	was	be	VBD	B-VP
O	481	485	used	use	VBN	I-VP
O	486	488	to	to	TO	B-VP
O	489	496	compare	compare	VB	I-VP
O	497	501	gene	gene	NN	B-NP
O	502	512	expression	expression	NN	I-NP
O	513	521	profiles	profile	NNS	I-NP
O	522	529	between	between	IN	B-PP
O	530	533	six	six	CD	B-NP
O	534	539	pairs	pair	NNS	I-NP
O	540	542	of	of	IN	B-PP
B-Cell	543	546	TFs	TF	NNS	B-NP
O	547	550	and	and	CC	O
O	551	557	normal	normal	JJ	B-NP
B-Cell	558	569	fibroblasts	fibroblast	NNS	I-NP
O	570	574	from	from	IN	B-PP
B-Cancer	575	585	esophageal	esophageal	JJ	B-NP
I-Cancer	586	594	squamous	squamous	JJ	I-NP
I-Cancer	595	599	cell	cell	NN	I-NP
I-Cancer	600	609	carcinoma	carcinoma	NN	I-NP
O	610	611	(	(	(	O
B-Cancer	611	615	ESCC	ESCC	NN	B-NP
O	615	616	)	)	)	O
O	616	617	.	.	.	O

O	618	632	Differentially	Differentially	RB	B-NP
O	633	642	expressed	express	VBN	I-NP
O	643	648	genes	gene	NNS	I-NP
O	649	653	were	be	VBD	B-VP
O	654	664	identified	identify	VBN	I-VP
O	664	665	,	,	,	O
O	666	669	and	and	CC	O
O	670	671	a	a	DT	B-NP
O	672	678	subset	subset	NN	I-NP
O	679	682	was	be	VBD	B-VP
O	683	692	evaluated	evaluate	VBN	I-VP
O	693	695	by	by	IN	B-PP
O	696	708	quantitative	quantitative	JJ	B-NP
O	709	713	real	real	JJ	I-NP
O	713	714	-	-	HYPH	I-NP
O	714	718	time	time	NN	I-NP
O	719	722	PCR	PCR	NN	I-NP
O	723	726	and	and	CC	I-NP
O	727	747	immunohistochemistry	immunohistochemistry	NN	I-NP
O	747	748	.	.	.	O

O	749	756	RESULTS	RESULTS	NNS	B-NP
O	756	757	:	:	:	O
O	758	763	About	About	IN	B-NP
O	764	766	43	43	CD	I-NP
O	766	767	%	%	NN	I-NP
O	768	769	(	(	(	O
O	769	772	126	126	CD	B-NP
O	773	775	of	of	IN	B-PP
O	776	779	292	292	CD	B-NP
O	779	780	)	)	)	O
O	781	783	of	of	IN	B-PP
O	784	789	known	know	VBN	B-NP
O	790	801	deregulated	deregulate	VBN	I-NP
O	802	807	genes	gene	NNS	I-NP
O	808	810	in	in	IN	B-PP
B-Cell	811	814	TFs	TF	NNS	B-NP
O	815	819	were	be	VBD	B-VP
O	820	830	associated	associate	VBN	I-VP
O	831	835	with	with	IN	B-PP
B-Cell	836	840	cell	cell	NN	B-NP
O	841	854	proliferation	proliferation	NN	I-NP
O	854	855	,	,	,	O
B-Cellular_component	856	869	extracellular	extracellular	JJ	B-NP
I-Cellular_component	870	876	matrix	matrix	NN	I-NP
O	877	887	remodeling	remodeling	NN	I-NP
O	887	888	,	,	,	O
O	889	892	and	and	CC	O
O	893	899	immune	immune	JJ	B-NP
O	900	908	response	response	NN	I-NP
O	908	909	.	.	.	O

O	910	912	Up	Up	RB	B-ADVP
O	912	913	-	-	HYPH	O
O	913	923	regulation	regulation	NN	B-NP
O	924	926	of	of	IN	B-PP
O	927	937	fibroblast	fibroblast	NN	B-NP
O	938	944	growth	growth	NN	I-NP
O	945	951	factor	factor	NN	I-NP
O	952	960	receptor	receptor	NN	I-NP
O	961	962	2	2	CD	B-NP
O	963	964	(	(	(	O
O	964	969	FGFR2	FGFR2	NN	B-NP
O	969	970	)	)	)	O
O	970	971	,	,	,	O
O	972	977	which	which	WDT	B-NP
O	978	984	showed	show	VBD	B-VP
O	985	988	the	the	DT	B-NP
O	989	993	most	most	RBS	I-NP
O	994	1005	significant	significant	JJ	I-NP
O	1006	1012	change	change	NN	I-NP
O	1012	1013	,	,	,	O
O	1014	1017	was	be	VBD	B-VP
O	1018	1026	detected	detect	VBN	I-VP
O	1027	1029	in	in	IN	B-PP
O	1030	1033	all	all	DT	B-NP
O	1034	1037	six	six	CD	I-NP
O	1038	1044	tested	test	VBN	I-NP
B-Cell	1045	1048	TFs	TF	NNS	I-NP
O	1049	1057	compared	compare	VBN	B-PP
O	1058	1062	with	with	IN	B-PP
O	1063	1068	their	their	PRP$	B-NP
O	1069	1075	paired	pair	VBN	I-NP
O	1076	1082	normal	normal	JJ	I-NP
B-Cell	1083	1094	fibroblasts	fibroblast	NNS	I-NP
O	1094	1095	.	.	.	O

O	1096	1097	A	A	DT	B-NP
O	1098	1105	further	further	JJ	I-NP
O	1106	1111	study	study	NN	I-NP
O	1112	1117	found	find	VBD	B-VP
O	1118	1122	that	that	IN	B-SBAR
B-Cell	1123	1128	FGFR2	FGFR2	NN	B-NP
I-Cell	1128	1129	-	-	HYPH	B-NP
I-Cell	1129	1137	positive	positive	JJ	I-NP
I-Cell	1138	1149	fibroblasts	fibroblast	NNS	I-NP
O	1150	1154	were	be	VBD	B-VP
O	1155	1159	only	only	RB	I-VP
O	1160	1168	observed	observe	VBN	I-VP
O	1169	1175	inside	inside	IN	B-PP
O	1176	1179	the	the	DT	B-NP
B-Tissue	1180	1185	tumor	tumor	NN	I-NP
I-Tissue	1186	1193	tissues	tissue	NNS	I-NP
O	1194	1197	and	and	CC	O
O	1198	1201	not	not	RB	B-PP
O	1202	1204	in	in	IN	I-PP
B-Tissue	1205	1210	tumor	tumor	NN	B-NP
I-Tissue	1210	1211	-	-	HYPH	O
I-Tissue	1211	1222	surrounding	surround	VBG	B-VP
I-Tissue	1223	1230	stromal	stromal	JJ	B-NP
I-Tissue	1231	1238	tissues	tissue	NNS	I-NP
O	1238	1239	,	,	,	O
O	1240	1250	suggesting	suggest	VBG	B-VP
O	1251	1255	that	that	IN	B-SBAR
O	1256	1261	FGFR2	FGFR2	NN	B-NP
O	1262	1267	could	could	MD	B-VP
O	1268	1270	be	be	VB	I-VP
O	1271	1275	used	use	VBN	I-VP
O	1276	1278	as	as	IN	B-PP
O	1279	1280	a	a	DT	B-NP
B-Cell	1281	1283	TF	TF	NN	I-NP
O	1283	1284	-	-	HYPH	B-NP
O	1284	1292	specific	specific	JJ	I-NP
O	1293	1299	marker	marker	NN	I-NP
O	1300	1302	in	in	IN	B-PP
B-Cancer	1303	1307	ESCC	ESCC	NNP	B-NP
O	1307	1308	.	.	.	O

O	1309	1317	Moreover	Moreover	RB	B-ADVP
O	1317	1318	,	,	,	O
O	1319	1322	the	the	DT	B-NP
O	1323	1334	conditioned	condition	VBN	I-NP
O	1335	1341	medium	medium	NN	I-NP
O	1342	1346	from	from	IN	B-PP
B-Cell	1347	1350	TFs	TF	NNS	B-NP
O	1351	1354	was	be	VBD	B-VP
O	1355	1360	found	find	VBN	I-VP
O	1361	1363	to	to	TO	I-VP
O	1364	1366	be	be	VB	I-VP
O	1367	1371	able	able	JJ	B-ADJP
O	1372	1374	to	to	TO	B-VP
O	1375	1382	promote	promote	VB	I-VP
B-Cell	1383	1387	ESCC	ESCC	NNP	B-NP
I-Cell	1388	1393	tumor	tumor	NN	I-NP
I-Cell	1394	1398	cell	cell	NN	I-NP
O	1399	1405	growth	growth	NN	I-NP
O	1405	1406	,	,	,	O
O	1407	1416	migration	migration	NN	B-NP
O	1416	1417	,	,	,	O
O	1418	1421	and	and	CC	O
O	1422	1430	invasion	invasion	NN	B-NP
O	1431	1433	in	in	FW	B-ADVP
O	1434	1439	vitro	vitro	FW	I-ADVP
O	1439	1440	.	.	.	O

O	1441	1452	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	1452	1453	:	:	:	O
O	1454	1457	Our	Our	PRP$	B-NP
O	1458	1463	study	study	NN	I-NP
O	1464	1472	provides	provide	VBZ	B-VP
O	1473	1476	new	new	JJ	B-NP
O	1477	1486	candidate	candidate	NN	I-NP
O	1487	1492	genes	gene	NNS	I-NP
O	1493	1496	for	for	IN	B-PP
O	1497	1500	the	the	DT	B-NP
B-Cancer	1501	1511	esophageal	esophageal	JJ	I-NP
I-Cancer	1512	1518	cancer	cancer	NN	I-NP
O	1519	1535	microenvironment	microenvironment	NN	I-NP
O	1535	1536	.	.	.	O

O	1537	1542	Based	Base	VBN	B-PP
O	1543	1545	on	on	IN	B-PP
O	1546	1549	our	our	PRP$	B-NP
O	1550	1557	results	result	NNS	I-NP
O	1557	1558	,	,	,	O
O	1559	1561	we	we	PRP	B-NP
O	1562	1573	hypothesize	hypothesize	VBP	B-VP
O	1574	1578	that	that	IN	B-SBAR
B-Cell	1579	1584	FGFR2	FGFR2	NN	B-NP
I-Cell	1584	1585	(	(	(	O
I-Cell	1585	1586	+	+	SYM	B-NP
I-Cell	1586	1587	)	)	)	O
I-Cell	1587	1588	-	-	HYPH	B-NP
I-Cell	1588	1591	TFs	TF	NNS	I-NP
O	1592	1597	might	might	MD	B-VP
O	1598	1605	provide	provide	VB	I-VP
B-Cell	1606	1612	cancer	cancer	NN	B-NP
I-Cell	1613	1618	cells	cell	NNS	I-NP
O	1619	1623	with	with	IN	B-PP
O	1624	1625	a	a	DT	B-NP
O	1626	1634	suitable	suitable	JJ	I-NP
O	1635	1651	microenvironment	microenvironment	NN	I-NP
O	1652	1655	via	via	IN	B-PP
O	1656	1665	secretion	secretion	NN	B-NP
O	1666	1668	of	of	IN	B-PP
O	1669	1677	proteins	protein	NNS	B-NP
O	1678	1682	that	that	WDT	B-NP
O	1683	1688	could	could	MD	B-VP
O	1689	1696	promote	promote	VB	I-VP
B-Cancer	1697	1703	cancer	cancer	NN	B-NP
O	1704	1715	development	development	NN	I-NP
O	1716	1719	and	and	CC	O
O	1720	1731	progression	progression	NN	B-NP
O	1732	1739	through	through	IN	B-PP
O	1740	1751	stimulation	stimulation	NN	B-NP
O	1752	1754	of	of	IN	B-PP
B-Cell	1755	1761	cancer	cancer	NN	B-NP
I-Cell	1762	1766	cell	cell	NN	I-NP
O	1767	1780	proliferation	proliferation	NN	I-NP
O	1780	1781	,	,	,	O
O	1782	1791	induction	induction	NN	B-NP
O	1792	1794	of	of	IN	B-PP
O	1795	1807	angiogenesis	angiogenesis	NN	B-NP
O	1807	1808	,	,	,	O
O	1809	1819	inhibition	inhibition	NN	B-NP
O	1820	1822	of	of	IN	B-PP
B-Cell	1823	1827	cell	cell	NN	B-NP
O	1828	1836	adhesion	adhesion	NN	I-NP
O	1836	1837	,	,	,	O
O	1838	1849	enhancement	enhancement	NN	B-NP
O	1850	1852	of	of	IN	B-PP
B-Cell	1853	1857	cell	cell	NN	B-NP
O	1858	1866	mobility	mobility	NN	I-NP
O	1866	1867	,	,	,	O
O	1868	1871	and	and	CC	O
O	1872	1881	promotion	promotion	NN	B-NP
O	1882	1884	of	of	IN	B-PP
O	1885	1888	the	the	DT	B-NP
B-Cell	1889	1899	epithelial	epithelial	JJ	I-NP
O	1899	1900	-	-	HYPH	I-NP
B-Cell	1900	1911	mesenchymal	mesenchymal	JJ	I-NP
O	1912	1922	transition	transition	NN	I-NP
O	1922	1923	.	.	.	O

